CHD4 and Down syndrome: Strong silencing effects were dependent on CHD4’s ATPase activity since mutations in the helicase domain, using the same mutation found in patients with CHD4-associated syndrome (Farnung et al., 2020; Weiss et al., 2020), did not reduce RNAPII aggregation and KSHV transcription (Figures 6B and 6C).